4DMedical@RSNA

See more in lung structure. Explore regional lung function.

Discover 4DMedical’s full product portfolio alongside contextflow lung detection software1. Explore quantitative insights into lung structure and CT:VQ’s non-contrast regional ventilation and perfusion analysis. For thoracic radiologists, it’s an opportunity to bring structural and functional findings into a more comprehensive assessment. Join us to discuss the questions that matter in your reading room—and to your referring clinicians.
 
 

View the entire 4DMedical portfolio.

1contextflow lung detection software is available in Europe and is not FDA-cleared in the United States.

What to Expect at RSNA 2026

Take a closer look at lung detection, quantitative structural analysis and regional function in one place.

Explore quantified lung density for additional insights into lung structure, CT:VQ for ventilation and perfusion assessment, and contextflow lung detection software alongside our full portfolio.

Bring your questions about chest CT interpretation, assessing lung disease and communicating structural and functional findings. Talk with our team about which insights would be most useful to your thoracic imaging practice.

Dr Amy Rohs
Pulmonologist, Critical Care Medicine, and Occupational Health Physician
Prof Catherine Jones
Cardiothoracic Radiologist
Dr Julie Bauml
Diagnostic Radiologist and Clinical Informatician

Tuesday, December 1 12:00–12:45pm  |  Center Stage South Hall 3352

 

CT pulmonary angiography has transformed pulmonary embolism diagnosis, but growing use means many scans are negative despite requiring iodinated contrast. Conventional nuclear medicine V/Q imaging provides valuable functional information but is limited by infrastructure, workflow, and access. Current PE guidance emphasizes clinical risk stratification to avoid unnecessary imaging in low-risk patients.

This multidisciplinary discussion explores how functional CT could bridge established approaches. Drawing on CT:VQ® clinical experience, the panel will examine how non-contrast chest CT could provide regional ventilation and perfusion information, expand functional lung imaging within existing CT workflows, and change when, where, and for whom V/Q information is available.

Bringing together perspectives from pulmonology and critical care, cardiothoracic radiology, imaging informatics, and clinical implementation, the panel will ask:

What if V/Q imaging were as accessible as a non-contrast chest CT?

The discussion will explore how accessible, non-contrast functional CT could complement existing PE diagnostic pathways, reduce reliance on iodinated contrast andspecialized nuclear medicine infrastructure, and extend ventilation and perfusion imaging beyond suspected PE to pulmonary vascular disease, unexplained breathlessness, and other areas of lung care.

Scientific Poster

Thursday, December 3
12:45 pm

Learning Center

"Democratizing Functional Lung Imaging - Validation Of Non-Contrast CT:VQ As A Sustainable Alternative To Dual-Energy CT In CTEPH"

Suraj Gowda, MBBS,MD

Thursday, December 3, 12:45pm  |  East Hall Learning Center

Can non-contrast CT expand access to functional lung imaging in CTEPH? This prospective study compared CT:VQ with dual-energy CT (DECT) iodine mapping in 71 evaluable patients. CT:VQ detected segmental perfusion defects with 95.4% sensitivity and 91.2% specificity, with excellent interobserver agreement (κ = 0.89) and strong correlation with DECT for lobar perfusion (r = 0.88; p < 0.001).

The findings support CT:VQ’s potential as a non-contrast approach using standard CT hardware, with possible applications in follow-up and surgical planning. Direct comparison with V/Q scintigraphy and environmental benefits were not evaluated in the reported methods or results.

Groundbreaking Technologies

CT Cardiopulmonary Assessment

  • CT:VQ™analyzes non-contrast CT scans to deliver quantified regional ventilation and perfusion maps and metrics for radiologists to report to referring clinicians.

  • CT LVAS™ provides clinicians with new, detailed information on regional lung ventilation to assess unexplained shortness of breath

  • CAC™ enables fast, accurate, and automated assessment of coronary artery calcification from CT scans, streamlining cardiovascular risk evaluation and aiding in early detection of heart disease1

  • IQ-UIP™ uses AI to automatically identify Usual Interstitial Pneumonia on CT scans with expert-level accuracy, streamlining diagnosis and enabling faster, more accessible specialist referrals1

  • LDAf™ is a fully automated tool that maps and quantifies normal lung, air-trapping, and emphysema from a CT scan, providing clear visualization of COPD and other lung conditions1

  • LDAi™ delivers fully automated detection and quantification of emphysema-related lung changes from standard low-dose CT scans, supporting lung cancer screening and smoking cessation counseling with easy-to-understand LungMap™ reports1

  • PHA™ automatically measures and reports the RV/LV ratio from CTPA scans, enabling rapid and accurate assessment of potential ventricular dilation in pulmonary hypertension1

  • XV LVAS® is lung airflow imaging software that processes conventional fluoroscopy scans to provide rich, functional lung health details unavailable via other modalities

In the News

Enhancing Patient Selection for Lung Volume Reduction Surgery: A Novel Quantitative CT Approach

Combining anatomical and functional information from non-contrast chest CT may give radiologists a more comprehensive imaging approach to support lung volume reduction surgery (LVRS) selection. In this retrospective, single-center study of 50 patients with upper-lung-predominant emphysema, investigators combined Parametric Response Mapping of emphysema with CT:VQ-derived perfusion from paired inspiratory and expiratory CT scans. Patients with upper-zone emphysema ≥ 50% and upper-zone perfusion ≤ 8% were more likely to achieve a postoperative FEV1 improvement ≥ 250 mL than those not meeting both thresholds (76.2% versus 24.1%; p < 0.001). The combined model significantly outperformed upper-zone emphysema assessment alone, highlighting the complementary value of regional perfusion in quantitative CT evaluation.

For the radiology community, these findings highlight the potential of chest CT to provide both structural disease characterization and functional information relevant to treatment planning within a single imaging examination. Patients meeting both thresholds also had higher rates of improvement in DLCO and six-minute walk distance. Deriving emphysema and perfusion measures from the same non-contrast CT examination may streamline the imaging work-up and reduce the need for separate perfusion scintigraphy, supporting clinical decision-making about LVRS candidacy. The authors call for larger, multicenter prospective studies to validate the approach and explore its application to other thoracic interventions.

Technical Validation, Clinical Applications, and Future Directions Across Perfusion Assessment, V/Q Mismatch, PE Detection, BLVR/LVRS Planning, and Precision Lung Surgery

This white paper examines the technical validation and clinical applications of CT:VQ, which generates quantitative, three-dimensional regional ventilation and perfusion maps from paired non-contrast inspiratory and expiratory CT scans, without contrast agents or radiotracers. Reported studies demonstrated correlations with dual-energy CT iodine maps for relative lobar perfusion (r = 0.921) and with SPECT V/Q for relative lobar ventilation (r = 0.833) and perfusion (r = 0.857). 

A prospective, multicenter study involving six radiologists and 77 subjects also found strong agreement between CT:VQ and SPECT perfusion assessments. These findings are complemented by analyses linking CT:VQ-derived functional measures to DLCO and spirometry.

Resource Center

What's new at 4DMedical

Get the latest news about respiratory imaging and ventilation analysis